Vivante Health’s Secures $31M to Transform Digestive Health with Novel Platform
Vivante Health recently announced a remarkable achievement in securing a $31 million Series B funding round, led by the Mercato Partners. This infusion of capital has propelled Vivante Health’s total funding to an impressive $47 million, reflecting the immense promise and potential of their innovative approach to gastrointestinal (GI) health.
At the core of Vivante Health’s offering is their cutting-edge platform known as GIThrive, a digital solution designed to provide personalized care plans for individuals grappling with digestive disorders. GIThrive empowers patients to take charge of their health by enabling them to track symptoms, access educational content, and engage with self-guided behavioral health modules. What sets GIThrive apart is its integrated care team, which includes dietitians, coaches, and healthcare physicians, all readily accessible through the platform.
The Illinois-based company’s recent funding success will be channeled into enhancing their technology and expanding their workforce, reaffirming their commitment to advancing GI health solutions. Bill Snyder, CEO of Vivante Health, articulated the company’s vision, stating, “One in four Americans suffers from a digestive disorder or undiagnosed digestive symptoms that affect their quality of life as well as their healthcare costs. We have proven that our scalable technology platform paired with our comprehensive care team results in better health, lower costs and a much better experience for the members we serve.”
Vivante Health’s remarkable journey of research and development has garnered significant attention and investment, with prior funding rounds including a $16 million Series A round in the previous year, a $5.8 million Series A1 investment in 2020, and a $6 million investment in 2018.
Their partnership with Solera Health, a digital platform specializing in benefits and chronic disease management programs, underscores the growing recognition of Vivante’s pioneering role in the field. As Vivante Health continues to make strides in digestive health, their all-in-one digital program, GIThrive, is poised to empower millions of individuals to reclaim their lives from digestive symptoms while significantly reducing healthcare costs for employers and health plans.
Vivante Health’s mission to tackle digestive diseases head-on is a testament to their dedication to improving the lives of millions and reshaping the landscape of GI health. With their innovative solutions, they offer hope and relief to those affected by digestive disorders, promising a brighter and healthier future for all.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
